相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。TTN/OBSCN 'Double-Hit' predicts favourable prognosis, 'immune-hot' subtype and potentially better immunotherapeutic efficacy in colorectal cancer
Zaoqu Liu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)
Survival and biomarker analyses from the OpACIN-neo and OpACIN neoadjuvant immunotherapy trials in stage III melanoma
E. A. Rozeman et al.
NATURE MEDICINE (2021)
The Burden of Head and Neck Cancer in the United States, 1990-2017
David C. Ludwig et al.
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2021)
Disruption of the HER3-PI3K-mTOR oncogenic signaling axis and PD-1 blockade as a multimodal precision immunotherapy in head and neck cancer
Zhiyong Wang et al.
NATURE COMMUNICATIONS (2021)
Association of RYR2 Mutation With Tumor Mutation Burden, Prognosis, and Antitumor Immunity in Patients With Esophageal Adenocarcinoma
Zaoqu Liu et al.
FRONTIERS IN GENETICS (2021)
The Impact of NOTCH Pathway Alteration on Tumor Microenvironment and Clinical Survival of Immune Checkpoint Inhibitors in NSCLC
Xiaohua Li et al.
FRONTIERS IN IMMUNOLOGY (2021)
PIK3CA Mutation in HPV-Associated OPSCC Patients Receiving Deintensified Chemoradiation
Brian T. Beaty et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2020)
Biomarkers for immunotherapy response in head and neck cancer
Niki Gavrielatou et al.
CANCER TREATMENT REVIEWS (2020)
Linsitinib (OSI-906) for the Treatment of Adult and Pediatric Wild-Type Gastrointestinal Stromal Tumors, a SARC Phase II Study
Margaret von Mehren et al.
CLINICAL CANCER RESEARCH (2020)
PRKDC: new biomarker and drug target for checkpoint blockade immunotherapy
Kien Thiam Tan et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Copy-Number Alteration Burden Differentially Impacts Immune Profiles and Molecular Features of Hepatocellular Carcinoma
Laia Bassaganyas et al.
CLINICAL CANCER RESEARCH (2020)
Characterization of the Immune Cell Infiltration Landscape in Head and Neck Squamous Cell Carcinoma to Aid Immunotherapy
Xinhai Zhang et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
PD-L1 Expression, Tumor Mutational Burden, and Cancer Gene Mutations Are Stronger Predictors of Benefit from Immune Checkpoint Blockade than HLA Class I Genotype in Non-Small Cell Lung Cancer
Marcelo V. Negrao et al.
JOURNAL OF THORACIC ONCOLOGY (2019)
Real-world systemic therapy treatment patterns for squamous cell carcinoma of the head and neck in Canada
K. Byrne et al.
CURRENT ONCOLOGY (2019)
The relation between PI3K/AKT signalling pathway and cancer
Saeed Noorolyai et al.
GENE (2019)
The changing therapeutic landscape of head and neck cancer
John D. Cramer et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Combination of TMB and CNA Stratifies Prognostic and Predictive Responses to Immunotherapy Across Metastatic Cancer
Li Liu et al.
CLINICAL CANCER RESEARCH (2019)
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study
Barbara Burtness et al.
LANCET (2019)
Tumor mutational load predicts survival after immunotherapy across multiple cancer types
Robert M. Samstein et al.
NATURE GENETICS (2019)
Immunotherapy for head and neck cancer: Recent advances and future directions
John D. Cramer et al.
ORAL ONCOLOGY (2019)
Oncogenic Signaling Pathways in The Cancer Genome Atlas
Francisco Sanchez-Vega et al.
CELL (2018)
Precision medicine in head and neck cancer
Orit Kaidar-Person et al.
DRUG RESISTANCE UPDATES (2018)
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
Peng Jiang et al.
NATURE MEDICINE (2018)
Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumab
David R. Gandara et al.
NATURE MEDICINE (2018)
Maftools: efficient and comprehensive analysis of somatic variants in cancer
Anand Mayakonda et al.
GENOME RESEARCH (2018)
The molecular landscape of head and neck cancer
C. Rene Leemans et al.
NATURE REVIEWS CANCER (2018)
Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
Aaron M. Goodman et al.
MOLECULAR CANCER THERAPEUTICS (2017)
AR Signaling and the PI3K Pathway in Prostate Cancer
Megan Crumbaker et al.
CANCERS (2017)
xCell: digitally portraying the tissue cellular heterogeneity landscape
Dvir Aran et al.
GENOME BIOLOGY (2017)
Complex heatmaps reveal patterns and correlations in multidimensional genomic data
Zuguang Gu et al.
BIOINFORMATICS (2016)
PI3K/AKT/mTOR: role in breast cancer progression, drug resistance, and treatment
Angel Guerrero-Zotano et al.
CANCER AND METASTASIS REVIEWS (2016)
Predictive biomarkers for checkpoint inhibitor-based immunotherapy
Geoffrey T. Gibney et al.
LANCET ONCOLOGY (2016)
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
R. L. Ferris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
deconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution
Rachel Rosenthal et al.
GENOME BIOLOGY (2016)
The role of the PI3K pathway in colorectal cancer
Dionysios Papadatos-Pastos et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2015)
Comprehensive genomic characterization of head and neck squamous cell carcinomas
Michael S. Lawrence et al.
NATURE (2015)
Robust enumeration of cell subsets from tissue expression profiles
Aaron M. Newman et al.
NATURE METHODS (2015)
p16 Protein Expression and Human Papillomavirus Status As Prognostic Biomarkers of Nonoropharyngeal Head and Neck Squamous Cell Carcinoma
Christine H. Chung et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
pRRophetic: An R Package for Prediction of Clinical Chemotherapeutic Response from Tumor Gene Expression Levels
Paul Geeleher et al.
PLOS ONE (2014)
Signaling by the Phosphoinositide 3-Kinase Family in Immune Cells
Klaus Okkenhaug
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
A patient-derived somatic mutation in the epidermal growth factor receptor ligand-binding domain confers increased sensitivity to cetuximab in head and neck cancer
El Mustapha Bahassi et al.
EUROPEAN JOURNAL OF CANCER (2013)
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov et al.
NATURE (2013)
Frequent Mutation of the PI3K Pathway in Head and Neck Cancer Defines Predictive Biomarkers
Vivian W. Y. Lui et al.
CANCER DISCOVERY (2013)
Integrative Genomic Characterization of Oral Squamous Cell Carcinoma Identifies Frequent Somatic Drivers
Curtis R. Pickering et al.
CANCER DISCOVERY (2013)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Association of BRCA1 and BRCA2 Mutations With Survival, Chemotherapy Sensitivity, and Gene Mutator Phenotype in Patients With Ovarian Cancer
Da Yang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Insulin-Mediated Acceleration of Breast Cancer Development and Progression in a Nonobese Model of Type 2 Diabetes
Ruslan Novosyadlyy et al.
CANCER RESEARCH (2010)
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
K. Kian Ang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Subclass Mapping: Identifying Common Subtypes in Independent Disease Data Sets
Yujin Hoshida et al.
PLOS ONE (2007)
Therapeutic outcome and side-effects after radiotherapy, chemotherapy and/or hyperthermia treatment of head and neck tumour xenografts
A Ressel et al.
EUROPEAN JOURNAL OF CANCER (2002)
分享论文
